If I were a betting man, I’d say you’re correct. Although, with matters as these it’s very difficult to know for sure. A possible alternative could involve the CF-Foundation finding out that the company could not stay afloat without hefty pricing on the drug, then selling their stock in order to avoid being connected with that publicity nightmare.
I’m not sure how much it cost’s to develop such a drug. Yes, we know a lot of the higher-ups got a lot richer very quickly. But, what does that equate to in terms of individual price inflation? I don’t know. But the answer would help us know just how much influence the CF-Foundation could’ve had on that $300,000 human price tag.
I’d be interested in looking deeper into this. Do you have any other references?